Testing a counseling message for increasing uptake of self-injectable contraception in southern Malawi: A mixed-methods, clustered randomized controlled study

Innovations in contraception provide users better options and allow greater opportunity to choose the method that best fits their desires and circumstances. One such innovation is subcutaneous depot medroxyprogesterone acetate (DMPA-SC), a self-injectable contraceptive that is packaged in a prefilled, easy-to-inject unit and provides three months of pregnancy prevention. Self-injection of DMPA-SC has been lauded as a game-changing option in the contraception method mix because of its potential to be more feasible and acceptable for users than existing options